The evolving landscape of tissue‐agnostic therapies in precision oncology

Documenti analoghi

• Treatment adaptation based on response to induction chemotherapy in nasopharyngeal carcinoma: An evolving landscape
  di: Nadia A. Saeed, et al.
  Pubblicazione: (2025)
• Pursuit of precision oncology in the treatment of metastatic hormone receptor–positive breast cancer: Making strides or barely moving?
  di: Ilana Schlam, et al.
  Pubblicazione: (2026)
• Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker‐driven therapeutics
  di: Laura V. M. Baum, et al.
  Pubblicazione: (2026)
• Regorafenib as maintenance therapy showed significant delayed progression of non‐adipocytic soft tissue sarcomas
  di: Carrie Printz
  Pubblicazione: (2025)
• Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey
  di: Sarah A. Pohl, et al.
  Pubblicazione: (2024)